A case of thoracic SMARCA4‐Deficient undifferentiated tumor successfully treated with combination Ipilimumab–Nivolumab

Yoshio Nakano; Daisuke Sekinada; Yusuke Kuze; Norio Okamoto; Iwao Gohma; Yumiko Yasuhara

doi:10.1002/ccr3.6745

Clinical Case Reports (Dec 2022)

A case of thoracic SMARCA4‐Deficient undifferentiated tumor successfully treated with combination Ipilimumab–Nivolumab

Yoshio Nakano,
Daisuke Sekinada,
Yusuke Kuze,
Norio Okamoto,
Iwao Gohma,
Yumiko Yasuhara

Affiliations

Yoshio Nakano: Department of Respiratory Medicine Sakai City Medical Center Sakai City Japan
Daisuke Sekinada: Department of Respiratory Medicine Sakai City Medical Center Sakai City Japan
Yusuke Kuze: Department of Respiratory Medicine Sakai City Medical Center Sakai City Japan
Norio Okamoto: Department of Respiratory Medicine Sakai City Medical Center Sakai City Japan
Iwao Gohma: Department of Respiratory Medicine Sakai City Medical Center Sakai City Japan
Yumiko Yasuhara: Department of Pathology Sakai City Medical Center Sakai City Japan

DOI: https://doi.org/10.1002/ccr3.6745
Journal volume & issue: Vol. 10, no. 12
pp. n/a – n/a

Abstract

Read online

Abstract Thoracic SMARCA4‐deficient undifferentiated tumors are rare, with poor prognosis. A 73‐year‐old man presented to our hospital with dyspnea. Computed tomography‐guided biopsy revealed a SMARCA4‐deficient undifferentiated tumor. The patient was treated with combination ipilimumab‐nivolumab. The tumor reduced in size after two courses.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904

About the journal

Abstract

Keywords